Steroids and recurrent IgA nephropathy after kidney transplantation

American Journal of Transplantation

Volumn 11, Issue 8, 2011, Pages 1645-1649

  Clayton, P ^a,b   McDonald, S ^a,c   Chadban, S ^a,b,d  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^c UNIVERSITY OF ADELAIDE   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

Author keywords

IgA nephropathy; recurrence; registry; steroids; transplantation

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; STEROID; TACROLIMUS;

ADULT; ARTICLE; DRUG USE; FEMALE; GRAFT FAILURE; GRAFT SURVIVAL; HLA MATCHING; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECURRENCE RISK; RECURRENT DISEASE; SURVIVAL;

ADULT; FEMALE; GLOMERULONEPHRITIS, IGA; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RECURRENCE;

EID: 79961064857     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2011.03667.x     Document Type: Article

References (14)

1. Barratt J, Feehally J,. IgA nephropathy. J Am Soc Nephrol 2005; 16: 2088-2097. (Pubitemid 41716440)
2. Odum J, Peh CA, Clarkson AR, et al,. Recurrent mesangial IgA nephritis following renal transplantation. Nephrol Dial Transplant 1994; 9: 309-312. (Pubitemid 24111584)
3. Ohmacht C, Kliem V, Burg M, et al,. Recurrent immunoglobulin A nephropathy after renal transplantation: A significant contributor to graft loss. Transplantation 1997; 64: 1493-1496. (Pubitemid 27513636)
4. Luan FL, Steffick DE, Gadegbeku C, Norman SP, Wolfe R, Ojo AO,. Graft and patient survival in kidney transplant recipients selected for de novo steroid-free maintenance immunosuppression. Am J Transplant 2009; 9: 160-168.
5. Woodle ES, First MR, Pirsch J, et al,. A prospective, randomized, double-blind, placebo-controlled multicenter trial comparing early (7 day) corticosteroid cessation versus long-term, low-dose corticosteroid therapy. Ann Surg 2008; 248: 564-577.
6. Barakat R, Molony DA, Samuels JA,. Immunosuppressive agents for treating IgA nephropathy. Cochrane Database of Systematic Reviews 2003, Issue 4. Art. No.: CD003965. Updated 2009.
7. McDonald SP, Russ GR,. Recurrence of IgA nephropathy among renal allograft recipients from living donors is greater among those with zero HLA mismatches. Transplantation 2006; 82: 759-762. (Pubitemid 44470378)
8. Fine JP, Gray RJ,. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999; 94: 496-509.
9. Mulay AV, van Walraven C, Knoll GA,. Impact of immunosuppressive medication on the risk of renal allograft failure due to recurrent glomerulonephritis. Am J Transplant 2009; 9: 804-811.
10. Briganti EM, Russ GR, McNeil JJ, Atkins RC, Chadban SJ,. Risk of renal allograft loss from recurrent glomerulonephritis. N Engl J Med 2002; 347: 103-109. (Pubitemid 34753480)
11. Berthoux F, El Deeb S, Mariat C, Diconne E, Laurent B, Thibaudin L,. Antithymocyte globulin (ATG) induction therapy and disease recurrence in renal transplant recipients with primary IgA nephropathy. Transplantation 2008; 85: 1505-1507.
12. Pascual J, Mezrich JD, Djamali A, et al,. Alemtuzumab induction and recurrence of glomerular disease after kidney transplantation. Transplantation 2007; 83: 1429-1434. (Pubitemid 46934065)
13. Lv J, Zhang H, Chen Y, et al,. Combination therapy of prednisone and ACE inhibitor versus ACE-inhibitor therapy alone in patients with IgA nephropathy: A randomized controlled trial. Am J Kidney Dis 2009; 53: 26-32.
14. Manno C, Torres DD, Rossini M, Pesce F, Schena FP,. Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy. Nephrol Dial Transplant 2009; 24: 3694-3701.